Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. - Wikidata - awgldk - TriplyDB

Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.

Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.

http://www.wikidata.org/entity/Q33816455

about

Targeting MicroRNA Function in Respiratory Diseases: Mini-Review Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype The exosomes in tumor immunity Regulation of immune responses by extracellular vesicles Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions Regulation of tumor metastasis by myeloid-derived suppressor cells Immunotherapeutic potential of extracellular vesicles Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune Suppression Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma The Influence of Ionizing Radiation on Exosome Composition, Secretion and Intercellular Communication Phenotype, development, and biological function of myeloid-derived suppressor cells Coordinated regulation of myeloid cells by tumours Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET Formation and role of exosomes in cancer.The functions and clinical applications of tumor-derived exosomes Exosomes: A Novel Strategy for Treatment and Prevention of Diseases.Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes.The pre-metastatic niche: finding common ground.Rapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins.Characterization of human plasma-derived exosomal RNAs by deep sequencing.Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice Exosomes and cancer: a newly described pathway of immune suppression.Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids.The roles of tumor-derived exosomes in cancer pathogenesis.Biodistribution and delivery efficiency of unmodified tumor-derived exosomes Exosomes in cancer: small particle, big player.Exosomal miRNAs: Biological Properties and Therapeutic Potential.MicroRNAs and other non-coding RNAs as targets for anticancer drug development.Microvesicles/exosomes as potential novel biomarkers of metabolic diseases Transcriptional regulation of myeloid-derived suppressor cells.The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.Exosomes and tumor-mediated immune suppression.Extracellular vesicles: communication, coercion, and conditioning Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis.Effects of notch signaling on regulation of myeloid cell differentiation in cancer.Isolation, identification, and characterization of novel nanovesicles Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro.

P2860

Q26766476-1352806D-810B-40B5-979E-24DBB99E8A4E Q26776113-8D90F6FE-7AEC-4E5C-9CE2-58684AE0807A Q26781172-01B8D2A0-FE24-44D3-8F33-A04CC5A3205C Q27006748-73500237-DD87-4C98-8038-6019917D9FA0 Q27008452-E6C1FF3F-CB0D-457F-8B89-02B4E6A1B0E8 Q27022125-7D695FF3-6038-41B6-B988-785EAB3F1F4E Q27023323-27945957-4E33-4929-85F0-A27B8157B91A Q28076769-9234E2D1-3418-4120-BDB7-D33D7B2A76EA Q28077635-AE1ED432-57DC-4C07-8C43-5C00FDCF45E7 Q28077661-DF80108E-C292-4571-BEC1-D278B20A88E8 Q28079046-4A84E9FD-5A75-4F75-80CA-7B57FCF8085F Q28395157-DC336021-0F7C-4681-B19C-51088A81ECD2 Q29618139-FD4DAC56-F1AC-4AB1-8B57-87DDBF3354C4 Q30303067-3EAC0D0C-52AC-4E3A-9ACD-B09ED7DB3B14 Q30361738-CB617844-7188-42FC-9A9A-DA0D2DFD3017 Q33791231-D038823D-E767-4A78-BE6F-F924A26C94B8 Q33795061-03845B6D-3038-4A26-873D-77A996B642C9 Q34162267-BD6BDFBA-3551-46EC-BDAE-E02B55C756E8 Q34342357-7920647D-7E54-4E4E-A960-089B9DFB8A96 Q34362246-0251BE4B-3E1A-4D91-9C98-A51F3C906B92 Q34714581-7D098656-0DFA-4322-8243-D50F1591F375 Q35147719-B4843919-D38D-4627-8D9F-09108B235C5D Q35162289-079ECD84-D7CD-4931-8408-03B7BB6986EF Q35285811-D9992021-33FA-4903-99C5-4A0ABB7F434A Q35410974-A1745FB4-AAE1-4E0E-A333-0252F5437877 Q35606520-DDCB7847-FEDD-4A78-850C-964820AA7CFC Q35636629-4F85790B-5860-4AD9-B8F8-DF4281858994 Q35834473-C103ECD9-1C54-424A-AC5C-2DD2B3A163F6 Q35899396-C08875FC-DDB1-4F0D-9311-7F5DCC5181F2 Q35994443-04AF4F2F-9623-4961-BA7C-B35EFEA1C97B Q36175435-DE5CA6B1-984A-4F63-ABB9-883D4599EA06 Q36322351-A6F734B7-E941-486E-8B68-E38842AA83D6 Q36685551-4F4078D7-8D5E-4D1D-98B8-CB729D39BB7B Q36737920-5919B773-39DD-4B44-B457-5483B5B1ADA3 Q36803149-08ED5E3A-F5A0-461D-BAEB-C5D003821A9E Q36847231-7A58B99C-BED6-4111-A1AA-690147047DFB Q36984496-DE185BC9-8735-4E39-9980-9F6B5763CE5B Q37456808-EB95FDE6-F699-4042-B0EB-FFDEAD212323 Q37520226-8F664C2E-BA4A-4A7F-9C8F-000B8B6054BC Q37535237-DA92C126-3AA2-4331-AA64-881A45FA7A51

P2860

Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.

http://www.wikidata.org/entity/Q33816455

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Contribution of MyD88 to the t ...... loid derived suppressor cells.

@ast

Contribution of MyD88 to the t ...... loid derived suppressor cells.

@en

type

label

Contribution of MyD88 to the t ...... loid derived suppressor cells.

@ast

Contribution of MyD88 to the t ...... loid derived suppressor cells.

@en

prefLabel

Contribution of MyD88 to the t ...... loid derived suppressor cells.

@ast

Contribution of MyD88 to the t ...... loid derived suppressor cells.

@en

P1433

Q33816455-1051481D-0AA0-47A1-A528-455AB4996A6D

P1476

Q33816455-B6D854AC-EECC-40B2-8DD7-A42FC41EB392

P2093

Q33816455-151777E4-57AF-421F-A2E9-BCA65E1D6BE0

Q33816455-1639BAF6-3BFE-4D40-9A6F-335D3CE58B12

Q33816455-2EC2C5E9-9573-42FF-9296-54B9810E815C

Q33816455-35A31B86-575B-4E7F-9B5F-DE1736D6CBD3

Q33816455-6CB952E7-9AEA-4CF1-8F1D-B1BCC0FC8FCB

Q33816455-E57BECB7-69D6-435C-BDC7-84566B0BACBA

Q33816455-EAF3C271-C179-4C71-A185-7432DCBD08C1

Q33816455-F069899B-2E00-47E0-9798-1A8960614CA5

Q33816455-F9F54A7E-83A5-4484-B45F-F2042D78F359

P2860

Q33816455-09B3A30B-C0CD-4CCE-863F-F3A6DA6E81AE

Q33816455-148B6EE0-F614-4446-9C22-08A715CFE317

Q33816455-1DE1E0CB-9CAE-4900-9798-009066760E92

Q33816455-270ADC00-2A57-4D68-BF74-37BBEC470FD8

Q33816455-31835E93-6040-4DBF-86CB-1A3088B1E01B

Q33816455-34FCC2B2-F77E-4E47-AB63-89F4786DE22D

Q33816455-3E73D024-A8E6-4ADF-816A-B4DB902ED0A2

Q33816455-40C3C294-D36B-4A2F-A969-E2294D6178F8

Q33816455-4B1E4AB4-0B25-4B79-8BDC-46C7795A9754

Q33816455-56486DC8-1B80-45D3-ABDC-660B91E1C665

P304

Q33816455-22289C35-38CB-49D1-B6E7-A4A8E2B6A4D0

P31

Q33816455-366B69B6-9100-419C-81A2-30BCC094DDD0

P356

Q33816455-B18D12B4-7E13-4DAD-9E5B-C2DBF03A9A95

P407

Q33816455-2C287A23-90E2-4E83-A7EA-16FA91AB1D25

P433

Q33816455-A8281716-FC82-464D-BFDA-24EE1EF51816

P478

Q33816455-025AA74A-F4EE-4EFB-B163-E9F14ED18CEC

P577

Q33816455-922BCC20-101D-465B-8B4B-91623452403D

P5875

Q33816455-5788D446-8D1E-4D0B-9188-CE76F529CA82

P698

Q33816455-8215BAA4-F7E8-490A-909A-2358F1146ADB

P932

Q33816455-DE1CEF6D-C504-486A-9D31-5F358833B4AB

P356

AJPATH.2010.090777

P1433

The American Journal of Pathology

P1476

Contribution of MyD88 to the t ...... loid derived suppressor cells.

@en

P2093

Cunren Liu

http://www.w3.org/2001/XMLSchema#string

Huang-Ge Zhang

http://www.w3.org/2001/XMLSchema#string

Shuangyin Zhang

http://www.w3.org/2001/XMLSchema#string

Sue Michalek

http://www.w3.org/2001/XMLSchema#string

William Grizzle

http://www.w3.org/2001/XMLSchema#string

Xiaoying Zhuang

http://www.w3.org/2001/XMLSchema#string

Xiaoyu Xiang

http://www.w3.org/2001/XMLSchema#string

Yuelong Liu

http://www.w3.org/2001/XMLSchema#string

Ziqiang Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor signalling

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

Inflammation and cancer

Myeloid-derived suppressor cells as regulators of the immune system

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

Toll-like receptors: critical proteins linking innate and acquired immunity

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.

P304

2490-2499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.090777

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42610943

http://www.w3.org/2001/XMLSchema#string

P698

20348242

http://www.w3.org/2001/XMLSchema#string

P932

2861113

http://www.w3.org/2001/XMLSchema#string